Zurück

Wählen Sie Ihre Region

Corporate

Europa:

Flagge Albanien Albanien Flagge Bosnien-Herzegowina Bosnien-Herzegowina Flagge Bulgarien Bulgarien Flagge Kroatien Kroatien Flagge Zypern Zypern Flagge Montenegro Montenegro Flagge Tschechien Tschechien Flagge Dänemark Dänemark Flagge Estland Estland Flagge Spanien Spanien Flagge Kosovo Kosovo Flagge Litauen Litauen Flagge Lettland Lettland Flagge Luxemburg Luxemburg Flagge Mazedonien Mazedonien Flagge Deutschland Deutschland Flagge Polen Polen Flagge Portugal Portugal Flagge Rumänien Rumänien Flagge Serbien Serbien Flagge Slowakei Slowakei Flagge Slowenien Slowenien Flagge Schweiz Schweiz Flagge Schweden Schweden Flagge Türkei Türkei Flagge Ungarn Ungarn Flagge Großbritannien Großbritannien Flagge Italien Italien

Asien:

Flagge UAE UAE Flagge Hong Kong Hong Kong Flagge Kuwait Kuwait Flagge Libanon Libanon

Afrika:

Flagge Südafrika Südafrika

Vereinbaren Sie ein Beratungsgespräch über Stammzellen

Mehr erfahren

Kontaktieren Sie uns noch heute!

Möchten Sie mehr über unsere Dienstleistungen erfahren? Füllen Sie das untenstehende Formular aus, und wir werden uns so schnell wie möglich mit Ihnen in Verbindung setzen, um Ihnen alle notwendigen Informationen zu geben und Ihre Fragen zu beantworten.

    Wir möchten Sie darauf hinweisen, dass die im Formular angegebenen personenbezogenen Daten von FamiCord Suisse mit Sitz in der Schweiz (BusinessPark Zug Sumpfstrasse 26, 6302 Zug) zur telefonischen Kontaktaufnahme im Zusammenhang mit der Erteilung von Serviceinformationen verarbeitet werden.

    Obraz

    Unsere
    Transplantationen

    Liste der Verwendungen von Stammzellen, die von den Laboren der FamiCord-Gruppe freigegeben wurden:

    Obraz
    Liste der Verwendungen von Stammzellen, die von den Laboren der FamiCord-Gruppe freigegeben wurden:
    Nr. Quelle Quellentyp Diagnose Medizinbereich Anwendungsjahr Therapie Land Alter des Empfängers
    5301 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 52
    5302 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 61
    5303 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 68
    5304 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 59
    5305 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 64
    5306 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 39
    5307 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 52
    5308 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 59
    5309 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 63
    5310 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 40
    5311 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 57
    5312 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 53
    5313 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 64
    5314 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 70
    5315 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 68
    5316 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 56
    5317 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 63
    5318 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 35
    5319 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 70
    5320 Apheresis Allogeneic Multiple Myeloma Hematology 2019 Standard Therapy Germany 57
    5321 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 41
    5322 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 60
    5323 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 68
    5324 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 65
    5325 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 63
    5326 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 65
    5327 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 66
    5328 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 57
    5329 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 65
    5330 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 67
    5331 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 64
    5332 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 70
    5333 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 64
    5334 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 66
    5335 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 68
    5336 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 58
    5337 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 59
    5338 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 72
    5339 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 65
    5340 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 62
    5341 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 55
    5342 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 62
    5343 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 14
    5344 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 61
    5345 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 61
    5346 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 75
    5347 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 45
    5348 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 70
    5349 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 72
    5350 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 69
    5351 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 45
    5352 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 40
    5353 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 65
    5354 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 72
    5355 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 50
    5356 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 59
    5357 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 66
    5358 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 61
    5359 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 42
    5360 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 68
    5361 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 65
    5362 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 56
    5363 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 63
    5364 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 62
    5365 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 64
    5366 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 42
    5367 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 68
    5368 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 61
    5369 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 68
    5370 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 62
    5371 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 66
    5372 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 66
    5373 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 67
    5374 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 4
    5375 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 56
    5376 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 66
    5377 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 62
    5378 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 61
    5379 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 61
    5380 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 63
    5381 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 44
    5382 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 45
    5383 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 33
    5384 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 66
    5385 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 65
    5386 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 49
    5387 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 69
    5388 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 71
    5389 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 25
    5390 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 42
    5391 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 46
    5392 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 65
    5393 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Germany 49
    5394 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Germany 66
    5395 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Germany 64
    5396 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Germany 67
    5397 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2019 Standard Therapy Germany 66
    5398 Apheresis Allogeneic Myelodysplastic Syndrome – Raeb Hematology 2019 Standard Therapy Poland 21
    5399 Apheresis Allogeneic Myelodysplastic Syndrome – Raeb Hematology 2019 Standard Therapy Poland 16
    5400 Apheresis Allogeneic Myelodysplastic Syndrome; Myeloproliferative Neoplasms Overlap Hematology 2019 Standard Therapy Germany 64